TY - JOUR
T1 - Current overview of the role of neuropeptides in ILC2s and future directions
AU - Irie, Misato
AU - Sasahara, Kotaro
AU - Artis, David
AU - Kabata, Hiroki
N1 - Funding Information:
The work is supported by Keio University Academic Development Funds , Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research , The Mochida Memorial Foundation for Medical and Pharmaceutical Research, KAKENHI, Grant-in-Aid for Young Scientists grants JP20K17193 (H.K.). Research in the Artis lab is supported by the National Institutes of Health ( DK126871 , AI151599 , AI095466 , AI095608 , AR070116 ), the Crohn's & Colitis Foundation , the Sackler Brain and Spine Institute Research , the LEO Foundation , Cure for IBD , The Rosanne H. Silbermann Foundation , Pamela and Arthur Sanders Family Foundation and Glenn Greenberg and Linda Vester Foundation .
Publisher Copyright:
© 2022 Japanese Society of Allergology
PY - 2022/7
Y1 - 2022/7
N2 - The neural and immune systems are closely connected, and recently, their molecular mechanisms and relationships with diseases have attracted substantial attention. Particularly, it has been increasingly reported that ILC2s, which produce type 2 cytokines independent of acquired immunity, are regulated by neuropeptides such as catecholamines, acetylcholine, vasoactive intestinal peptide, neuromedins, and calcitonin gene-related peptide. However, the regulatory mechanisms in this regard are only partially understood, implying that further studies are still needed to clarify the complete mechanisms and processes. In this review, we summarize current reports on the regulatory effect of neuropeptides on ILC2s, some of which have conflicting results, possibly owing to the complexity of G-protein coupled receptors. By summarizing the current evidence, we hope to be able to identify what is currently unknown as well as what needs to be clarified in the future.
AB - The neural and immune systems are closely connected, and recently, their molecular mechanisms and relationships with diseases have attracted substantial attention. Particularly, it has been increasingly reported that ILC2s, which produce type 2 cytokines independent of acquired immunity, are regulated by neuropeptides such as catecholamines, acetylcholine, vasoactive intestinal peptide, neuromedins, and calcitonin gene-related peptide. However, the regulatory mechanisms in this regard are only partially understood, implying that further studies are still needed to clarify the complete mechanisms and processes. In this review, we summarize current reports on the regulatory effect of neuropeptides on ILC2s, some of which have conflicting results, possibly owing to the complexity of G-protein coupled receptors. By summarizing the current evidence, we hope to be able to identify what is currently unknown as well as what needs to be clarified in the future.
KW - Group 2 innate lymphoid cells
KW - IL-33
KW - Neuro-immune interactions
KW - Neurons
KW - Type 2 inflammation
UR - http://www.scopus.com/inward/record.url?scp=85127533765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127533765&partnerID=8YFLogxK
U2 - 10.1016/j.alit.2022.03.002
DO - 10.1016/j.alit.2022.03.002
M3 - Review article
C2 - 35367135
AN - SCOPUS:85127533765
SN - 1323-8930
VL - 71
SP - 294
EP - 300
JO - Allergology International
JF - Allergology International
IS - 3
ER -